Lowest Glucagon/Highest C-Peptide in Oral Glucose Tolerance Test: Clinical Utility in Monitoring Glucose Control in Type 2 Diabetes Mellitus.

Lina ChangXiaohui MaMenghua YuanLi DingYian GuLili LiuYan LiHua ShuMing LiuQing He

Published in: Diabetes, metabolic syndrome and obesity : targets and therapy (2024)

Lglc/Hcp in OGTT closely relates to blood glucose control in patients with T2DM, potentially reflecting the overall pancreatic islet function in regulating glucose levels. Moreover, inhibiting glucagon secretion may be a crucial consideration for patients requiring insulin treatment.

Keyphrases

blood glucose
glycemic control
end stage renal disease
type diabetes
newly diagnosed
chronic kidney disease
ejection fraction
blood pressure
prognostic factors
peritoneal dialysis
signaling pathway
insulin resistance
adipose tissue
metabolic syndrome
patient reported